SNDX News and Press, Syndax Pharmaceuticals Inc. From 09/27/21

Puhui Wealth Investment (NASDAQ:PHCF) +55%. Red Cat Holdings RCAT +50% after subsidiary receives five-year contract with NASA Paltalk (NASDAQ:PALT) +36%. Vinco Ventures (NASDAQ:BBIG) +16%. VIZIO Holding (NYSE:VZIO) +10%. U.S. Energy (NASDAQ:USEG) +8%. Syndax Pharmaceuticals (NASDAQ:...

Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases - Syndax to receive $ 152 million in cash ($117 million upfront plus a $35 million equity investment, with po...

Syndax Appoints Martin H. Huber, M.D., to its Board of Directors PR Newswire WALTHAM, Mass. , Sept. 15, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing ...

The following slide deck was published by Syndax Pharmaceuticals, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Syndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation

Syndax Pharmaceuticals, Inc. (SNDX) Q2 2021 Earnings Conference Call August 09, 2021, 16:30 ET Company Participants Melissa Forst - Argot Partners Briggs Morrison - CEO & Director Daphne Karydas - CFO Michael Meyers - Chief Medical Officer & SVP Conference Call Participants Philip Nad...

Syndax Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Business Update - Intermediate doses selected for Phase 2 portion of AUGMENT-101 trial of SNDX-5613 in patients with genetically-defined acute leukemias; updated results from Phase 1 p...

Syndax to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021 PR Newswire WALTHAM, Mass. , Aug. 2, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical sta...

SNDX-5613 Granted FDA Fast Track Designation for the Treatment of Relapsed/Refractory Acute Leukemias PR Newswire WALTHAM, Mass. , June 28, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopha...

Syndax Announces Participation in Goldman Sachs 42nd Annual Global Healthcare Conference PR Newswire WALTHAM, Mass. , June 3, 2021 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutic...

Canopy set for growth on Canadian economy re-openingWhile not expecting a significant Q4 2021 beat for Canopy Growth (CGC) on June 1, MKM expects a turnaround as the Canadian economy starts to re-open.As a result, the firm is upgrading shares from neutral to buy with a C$55 price target.That ...